News

Transgene has employed a novel gene silencing (within RNAi platform) technology to develop this drug. The technology involves highly selective knock-down of specific liver cancer producing gene targets,

Avrio’s newly built, 20,000 square foot, aseptic fill-and-finish facility includes three aseptic suites and five production suites with each suite having its own dedicated air handling system. In

With this Agendia has obtained all major US clinical laboratory licenses with this permit. In addition, the College of American Pathologists (CAP) has accredited Agendia’s CLIA regulated laboratory

The company has informed that the US patent number: 7,659,282 titled ‘Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders’, was issued on February 9,

As claimed, the Xcelodose system can help reduce processing time and API usage in simple formulations of API or powder-in-capsule, when compared to traditional methods. Manufactured by Capsugel,

This approval represents the final national regulatory step in taking the ReN001 therapy into patients in the UK, following regulatory approval from the UK Medicines and Healthcare Products

Posiphen, a small orally active compound, has shown in cell cultures of normal mice, AD transgenic mice and down syndrome (DS) mice to reduce the synthesis of amyloid-ß

The molecules include novel imaging and radiotherapeutic agents for Epstein Barr Virus (EBV) associated tumors and prostate cancer. The EBV technology, published in the October 2008 issue of

The Paragon HIS will be the foundation of the health system’s use of McKesson solutions for document management and medical imaging. New for Citrus Memorial will be a